The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
BIRB796 Inhibits All p38 MAPK Isoforms in Vitro and in Vivo
Open accessAbstract
The compound BIRB796 inhibits the stress-activated protein kinases p38alpha and p38beta and is undergoing clinical trials for the treatment of inflammatory diseases. Here we report that BIRB796 also inhibits the activity and the activation of SAPK3/p38gamma. This occurs at higher concentrations of BIRB796 than those that inhibit p38alpha and p38beta and at lower concentrations than those that inhibit the activation of JNK isoforms. We also show that at these concentrations, BIRB796 blocks the stress-induced phosphorylation of the scaffold protein SAP97, further establishing that this is a physiological substrate of SAPK3/p38gamma. Our results demonstrate that BIRB796, in combination with SB203580, a compound that inhibits p38alpha and p38beta, but not the other p38 isoforms, can be used to identify physiological substrates of SAPK3/p38gamma as well as those of p38alpha and p38beta.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
Hanks, S. K., Quinn, A. M., & Hunter, T. (1988) · Science · doi:10.1126/science.3291115 · Cited by 5,039
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,393
Self-citationKyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,382
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
(1995) · FEBS Letters · doi:10.1016/0014-5793(95)00357-f · Cited by 2,086
The specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369
Self-citationTreatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions
Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., Wang, Y.-T., Salter, M. W., & Tymianski, M. (2002) · Science · doi:10.1126/science.1072873 · Cited by 999
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
Pargellis, C., Tong, L., Churchill, L., Cirillo, P. F., Gilmore, T., Graham, A. G., Grob, P. M., Hickey, E. R., Moss, N., Pav, S., et al. (2002) · Nature Structural Biology · doi:10.1038/nsb770 · Cited by 833
The search for physiological substrates of MAP and SAP kinases in mammalian cells
COHEN, P. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01105-7 · Cited by 536
Activation of the Protein Kinase ERK5/BMK1 by Receptor Tyrosine Kinases
Kamakura, S., Moriguchi, T., & Nishida, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26563 · Cited by 510
Cuenda, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.2.295 · Cited by 362
Self-citationPyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate
Regan, J., Breitfelder, S., Cirillo, P., Gilmore, T., Graham, A. G., Hickey, E., Klaus, B., Madwed, J., Moriak, M., Moss, N., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020057r · Cited by 348
Cuenda, A., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4341 · Cited by 329
Self-citationEyers, P. A., Craxton, M., Morricel, N., Cohen, P., & Goedert, M. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90170-3 · Cited by 310
Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway
Mody, N., Leitch, J., Armstrong, C., Dixon, J., & Cohen, P. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02651-5 · Cited by 250
Branger, J., van den Blink, B., Weijer, S., Madwed, J., Bos, C. L., Gupta, A., Yong, C.-L., Polmar, S. H., Olszyna, D. P., Hack, C. E., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.4070 · Cited by 233
p38γ regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP
Sabio, G., Arthur, J. S. C., Kuma, Y., Peggie, M., Carr, J., Murray‐Tait, V., Centeno, F., Goedert, M., Morrice, N. A., & Cuenda, A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600578 · Cited by 228
Self-citationStress-activated Protein Kinase-3 Interacts with the PDZ Domain of α1-Syntrophin
Hasegawa, M., Cuenda, A., Spillantini, M. G., Thomas, G. M., Buée-Scherrer, V., Cohen, P., & Goedert, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12626 · Cited by 158
Self-citationFeijoo, C., Campbell, D. G., Jakes, R., Goedert, M., & Cuenda, A. (2005) · Journal of Cell Science · doi:10.1242/jcs.01655 · Cited by 133
Self-citationSabio, G., REUVER, S., Feijóo, C. G., Hasegawa, M., Thomas, G. M., Centeno, F., Kuhlendahl, S., Leal‐Ortiz, S., Goedert, M., Garner, C. C., et al. (2004) · Biochemical Journal · doi:10.1042/bj20031628 · Cited by 92
Self-citationBranger, J., van den Blink, B., Weijer, S., Gupta, A., van Deventer, S. J. H., Hack, C. E., Peppelenbosch, M. P., & van der Poll, T. (2003) · Blood · doi:10.1182/blood-2002-11-3338 · Cited by 80
Kuma, Y., Campbell, D. G., & Cuenda, A. (2004) · Biochemical Journal · doi:10.1042/bj20031559 · Cited by 55
Self-citationHaydon, C. E., Watt, P., MORRICE, N. A., Knebel, A., Gaestel, M., & Cohen, P. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2625 · Cited by 20
Cited by
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., Mclauchlan, H., Klevernic, I., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,520
Self-citationp38 MAP-Kinases pathway regulation, function and role in human diseases
Cuenda, A., & Rousseau, S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.010 · Cited by 1,400
Self-citationTNF and MAP kinase signalling pathways
Sabio, G., & Davis, R. J. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.02.009 · Cited by 700
Self-citationThe mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1
Plun-Favreau, H., Klupsch, K., Moisoi, N., Gandhi, S., Kjaer, S., Frith, D., Harvey, K., Deas, E., Harvey, R. J., McDonald, N., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1644 · Cited by 479
Rational Approaches to Improving Selectivity in Drug Design
Huggins, D. J., Sherman, W., & Tidor, B. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2010332 · Cited by 367
Metadata
- Authors
- Kuma, Y., Sabio, G., Bain, J., Shpiro, N., Márquez, R., & Cuenda, A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 280
- Issue
- 20
- Pages
- 19472-19479
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2147510335
- Cited by
- 304
- References
- 24
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.